Semler Scientific Inc. reported its financial results for the first quarter ended March 31, 2025. The company experienced a significant decline in revenues, reporting $8.8 million, which marks a 44% decrease compared to the same period last year. The cost of revenues was $0.9 million, reflecting a 25% year-over-year decrease. The company also reported a net loss of $64.7 million, or $6.74 per basic and diluted share, compared to a net income of $6.1 million for the first quarter of 2024. This change represents a notable downturn in the company's financial performance. Semler Scientific's income tax benefit for the quarter was $10.2 million, with an effective tax benefit rate of 14%, compared to an expense of $1.7 million, or an effective tax rate of 22%, in the first quarter of 2024. The company's two largest customers, including their affiliates, accounted for 42% and 32% of the revenues for the first quarter of 2025, respectively. In 2024, its three largest customers contributed 45%, 25%, and 11% to the first quarter revenues. In addition to the financial results, Semler Scientific announced that it will provide a business update on its near-term strategies during a conference call, with the information being accessible through its website dashboard.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.